Hexamethylmelamine as a single second-line agent in ovarian cancer

Gynecologic Oncology
A ManettaP S Schein

Abstract

Fifty-two patients with advanced ovarian cancer were treated with single-agent hexamethylmelamine (HMM), 260 mg/m2 po per day for 14 days followed by 14 days off drug. All patients had been previously treated with chemotherapy. Of these patients, 92% (48/52) received cisplatin and cyclophosphamide +/- doxorubicin prior to hexamethylmelamine. Two additional patients received other cisplatin-based regimens. Fifteen percent (8/52) were found to have no evidence of disease (NED) at the completion of treatment with HMM. Five of these patients are alive at 12 to 65 months (median follow-up of 32 months); one patient died at 41 months of an intercurrent illness with no clinical evidence of recurrence; two patients died of recurrent tumor at 21 and 31 months. The median survival of the series of 52 patients is 11 months: 9 months for patients who did not respond versus 41 months for patients with NED post-HMM (P less than 0.05). The regimen was well tolerated: moderate gastrointestinal toxicity was reported by 8 patients; only one patient reported severe gastrointestinal toxicity. Moderate neurologic toxicity (primarily sensory) was reported by 5 patients, 3 patients experienced white counts less than 2000 or platelet counts less than ...Continue Reading

References

Mar 1, 1977·Gynecologic Oncology·C R StanhopeF Rutledge

❮ Previous
Next ❯

Citations

Nov 4, 1996·International Journal of Cancer. Journal International Du Cancer·H M ColeyI R Judson
Dec 21, 2000·Current Oncology Reports·A A Garcia
Jan 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G ZanettaC Mangioni
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D V SkarlosG Fountzilas
Jan 1, 1995·Critical Reviews in Oncology/hematology·M A Morgan, S C Rubin
Jan 14, 2000·Critical Reviews in Oncology/hematology·N ColomboA Maggioni
Jul 16, 1992·The New England Journal of Medicine·C O Granai
Nov 18, 1993·The New England Journal of Medicine·S A Cannistra
Aug 7, 2003·American Journal of Clinical Oncology·Shonda Davis-PerryRachel Shank
Sep 11, 1991·American Journal of Obstetrics and Gynecology·D H MooreL S Crumpler
Mar 1, 1992·Current Problems in Cancer·R F Ozols
Mar 1, 1991·Cancer Treatment Reviews·P S ScheinW McCulloch
Dec 11, 1992·Gynecologic Oncology·F Muggia, K Norris
Dec 1, 1992·Gynecologic Oncology·I VergoteC Tropé
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S ChiaraR Rosso
Sep 6, 2005·Gynecologic Oncology·Sharyn N LewinThomas J Herzog
Jan 1, 1992·Cancer Investigation·R J Schilder, R F Ozols
Jan 5, 2002·Expert Opinion on Investigational Drugs·M Harries, S B Kaye
Sep 23, 1997·Gynecologic Oncology·E M SwisherT J Herzog
Feb 15, 1993·Cancer·J T ThigpenT Khansur
Jan 1, 1992·Hematological Oncology·R F Ozols
Jan 1, 1992·Acta Obstetricia Et Gynecologica Scandinavica. Supplement·R F Ozols
Feb 1, 1991·DICP : the Annals of Pharmacotherapy·L A Hansen, T E Hughes
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C DoyleA M Oza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.